LogiPharma: AI and machine learning rise among pharma supply-chain investment priorities

Pharma supply chains provide a useful test of whether AI investment intent can survive regulated operating processes. Forecasting and inventory use cases may be attractive, but validation, explainability and change control can determine whether models actually enter planning decisions.